BBC Virtus Biotech Clinical Trials ETF Loading...

Loading chart...
Top Calls

Price change since each call, adjusted for long/short direction. Results calculated:

Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
Time Author Thesis Company / ticker Signal Since call Position Source
05:39
Oct 15
seedy19tron
Biotech flow forecast includes BBC News
Biotech ETF appears in the same flow forecast, with consensus names expected to recover losses before year-end.
BBC Virtus Biotech Clinical Trials ETF Long 1ST — —
16:22
May 19
A May MD
Bearish view on biotech (XBI/BBC) if rates remain elevated.
Bearish view on biotech (XBI/BBC) if rates remain elevated; the speaker expects a return to the prolonged bearish period for the sector unless rates ease.
BBC Virtus Biotech Clinical Trials ETF Avoid — —

About BBC Investor Commentary

Across the available history and selected sources, Buzzberg tracks BBC (Virtus Biotech Clinical Trials ETF) across 2 sources: 1 bullish vs 0 bearish calls from 2 authors. Historical directional balance: 14% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 7 total trade ideas tracked. Past 7 days, before deduplication: 1 bullish, 1 other directions. Latest voices: seedy19tron, A May MD.